Waystar initiated with an Outperform at BMO Capital

BMO Capital initiated coverage of Waystar (WAY) with an Outperform rating and $47 price target Waystar’s integrated software helps healthcare providers address major billing and collections challenges, the analyst tells investors in a research note. Its strong data assets, AI investments, and long runway for expansion support sustained low double-digit revenue growth and 40% EBITDA margins, offering a growth and margin profile similar to other vertical software peers but at a more attractive valuation, the firm says.